经导管动脉化疗栓塞术对肝癌转移潜能的影响

Value of detection of molecules associated with drug sensitivity in individualized chemoembolization for hepatocellular carcinoma

AIM: To investigate the value of detection of molecules associated with drug sensitivity in preventive transcatheter arterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) after hepatectomy.

METHODS: A total of 92 patients with HCC receiving preventive TACE within three months after hepatectomy were divided into an observation group (n = 50) and a control group (n = 42). In the observation group, chemotheraputic agents were selected based on the detection of molecules associated with drug sensitivity, while chemotheraputic agents were chosen empirically in the control group. The one-year recurrence rate, side effects of TACE and disease-free survival time were compared between the two groups.

RESULTS: The one-year recurrence rate in the observation group was lower than that of the control group (χ² = 4.422, P = 0.035). The difference in disease-free survival time between the two groups was of statistical significance (t = 3.081, P = 0.003). The disease-free survival curve of the observation group differed from that of the control group (χ² = 5.99, P = 0.014). The incidence rates of nausea, emesis, diarrhea, and leukopenia in the observation group after TACE were significantly lower than those of the control group (P < 0.05). The difference in the incidence rate of fever after TACE had no statistical difference between the two groups (χ² = 0.091, P = 0.763).

CONCLUSION: Selection of chemotheraputic agents based on detection of molecules can delay recurrence, prolong disease-free survival time and reduce the incidence of side effects after TACE in patients with HCC after hepatectomy.